Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chianese

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cytometry|January 1, 1990
Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometryM L Kelsten, M S Berger, H C Maguire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2014
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccineYinin Hu, Gina R Petroni, Walter C Olson, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2013
Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptideElise P Salerno, Sofia M Shea, Walter C Olson, et al.
Nature Communications|March 23, 2024
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1995
Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migrationO Reiner, U Albrecht, M Gordon, et al.
Journal of Translational Medicine|March 10, 2011
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic functionWalter C Olson, Mark E Smolkin, Erin M Farris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccineCraig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)Craig L Slingluff, Sandra Lee, Fengmin Zhao, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cytometry|January 1, 1990
Analysis of c-erbB-2 protein expression in conjunction with DNA content using multiparameter flow cytometryM L Kelsten, M S Berger, H C Maguire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanomaGeoffrey R Weiss, William W Grosh, Kimberly A Chianese-Bullock, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2014
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccineYinin Hu, Gina R Petroni, Walter C Olson, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2013
Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptideElise P Salerno, Sofia M Shea, Walter C Olson, et al.
Nature Communications|March 23, 2024
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1995
Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migrationO Reiner, U Albrecht, M Gordon, et al.
Journal of Translational Medicine|March 10, 2011
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic functionWalter C Olson, Mark E Smolkin, Erin M Farris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccineCraig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)Craig L Slingluff, Sandra Lee, Fengmin Zhao, et al.
Journal for Immunotherapy of Cancer|August 16, 2014
A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodesPatrick M Dillon, Walter C Olson, Andrea Czarkowski, et al.
Pageof 6